Realtime | Geld | Brief | Zeit |
---|---|---|---|
1,035 | 1,065 | 11:00 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
21.08. | Mentice AB: Mentice receives approximately SEK 31.95 million through oversubscribed rights issue | 101 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA... ► Artikel lesen | |
01.08. | Mentice AB: Mentice receives an additional Subscription Commitment of 3.4 MSEK in the upcoming Rights Issue | 104 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA... ► Artikel lesen | |
31.07. | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.07.2025 | 230 | Xetra Newsboard | Das Instrument MN2 SE0012673291 MENTICE AB SK -,20 EQUITY wird ex Kapitalmassnahme gehandelt am 31.07.2025 The instrument MN2 SE0012673291 MENTICE AB SK -,20 EQUITY is traded ex capital adjustment on... ► Artikel lesen | |
24.07. | Mentice AB: Schwäche im APAC-Geschäft belastet Q2-Ergebnis und Aktie | 1 | Investing.com Deutsch | ||
24.07. | Mentice AB: Mentice resolves on a rights issue of approximately SEK 31.95 million | 159 | GlobeNewswire (Europe) | The Board of Directors of Mentice AB (publ) ("Mentice" or the "Company"), (Nasdaq First North Premium Growth Market) has today, based on the authorization granted by the annual general meeting on 27... ► Artikel lesen | |
24.07. | Mentice AB: Mentice publishes the company's interim report for the period April-June 2025 | 116 | GlobeNewswire (Europe) | IMPORTANT STRATEGIC STEPS TAKEN
SIGNIFICANT EVENTS DURING THE SECOND QUARTER 2025 (APR - JUN)Mentice announced a strategic workforce realignment aimed at optimizing its organizational structure and... ► Artikel lesen | |
11.07. | Mentice AB: Mentice AB Announces Consolidation of Physical Simulation Operations to Strengthen Long-Term Efficiency and Global Service Delivery | 245 | GlobeNewswire (Europe) | Gothenburg, Sweden, July 11, 2025 - Mentice AB (publ), a global leader in simulation solutions for image-guided therapies, today announces the decision to consolidate its research and development (R&D)... ► Artikel lesen | |
16.06. | Mentice AB: Mentice AB announces the intent for a strategic workforce realignment to enhance focus and operational efficiency and the intent for a rights issue of max 10% of the share capital | 168 | GlobeNewswire (Europe) | Mentice AB (publ), a globally recognized leader in simulation solutions for image-guided interventional therapies, today announces the intent of a strategic workforce realignment and the intent of planning... ► Artikel lesen | |
MENTICE Aktie jetzt für 0€ handeln | |||||
09.05. | MENTICE AB: Mentice's CEO to "We anticipate a further ramp up in our sales" | 1 | Cision News | ||
08.05. | Mentice AB: Mentice publishes the company's interim report for the period January-March 2025 | 122 | GlobeNewswire (Europe) | STABLE GROWTH AND STRATEGIC CHANGES IN THE FIRST QUARTER
SIGNIFICANT EVENTS DURING THE FIRST QUARTER 2025 (JAN - MAR)Mentice announced a significant order from a top 20 global Med Tech company for 6.5... ► Artikel lesen | |
07.05. | MENTICE AB: Mentice launches Ankyras in Brazil | 1 | Cision News | ||
17.04. | Mentice AB: Mentice AB Publishes Annual and Sustainability Report for 2024 - Strong finish to 2024 following a transitional year | 166 | GlobeNewswire (Europe) | Mentice AB (publ), Gothenburg - a globally recognized leader in simulation solutions for image-guided interventional therapies, today published its Annual Report and Sustainability Report for 2024.
The... ► Artikel lesen | |
13.02. | Mentice AB: Mentice publishes the company's year-end report for the period January-December 2024 | 140 | GlobeNewswire (Europe) | STRONG CLOSING QUARTER
SIGNIFICANT EVENTS DURING THE FORTH QUARTER 2024 (OCT - DEC)Mentice announced the recruitment of Frans Venker as new CEO, starting Jan 1, 2025.The order intake during the quarter... ► Artikel lesen | |
03.02. | Research and Markets: Europe Surgical Robotics Simulation Market Research 2024-2033, Profiles of Fundamental Surgery, Metall-Zug, Mentice, Surgical Science Sweden, VirtaMed, VOXEL-MAN - ResearchAndMarkets.com | 487 | Business Wire | The "Europe Surgical Robotics Simulation Market: Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering.
The Europe surgical robotics simulation market was... ► Artikel lesen | |
28.11.24 | Mentice AB: Announcement of New CEO Appointment | 428 | GlobeNewswire (Europe) | Mentice (publ), Gothenburg, a globally recognized leader in simulation solutions for image-guided interventional therapies, announced today the appointment of Frans Venker as its new Chief Executive... ► Artikel lesen | |
07.11.24 | Mentice AB: Mentice publishes the company's interim report for the period July - September 2024 | 195 | GlobeNewswire (Europe) | A challenging summer quarter at the level of last year
SIGNIFICANT EVENTS DURING THE THIRD QUARTER 2024 (JUL - SEP)Mentice and AGIK, the Working Group of Interventional Cardiology within the German... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ECKERT & ZIEGLER | 17,630 | -0,68 % | BERENBERG stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Eckert & Ziegler mit einem Kursziel von 24 Euro auf "Buy" belassen. Unternehmenschef Harald Hasselmann habe seine positive... ► Artikel lesen | |
PENUMBRA | 215,30 | +0,37 % | Penumbra, Inc. Reports Second Quarter 2025 Financial Results | ALAMEDA, Calif., July 29, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 17,450 | 0,00 % | Alignment Healthcare USA, LLC: Aging in Place, Limited Access to Medical Care and Economic Insecurity Threaten U.S. Senior Health | ||
PRIVIA HEALTH GROUP | 24,420 | 0,00 % | Privia Health buys Evolent Health's ACO business for $100M | ||
PROGYNY | 21,420 | 0,00 % | A Healthcare Debate: Progyny vs. Hims & Hers | ||
SIEMENS HEALTHINEERS | 46,050 | +0,99 % | Siemens Healthineers, Carl Zeiss Meditec und Co fallen - das ist der Grund | Die Aktie von Siemens Healthineers befindet sich am Donnerstag unter den größten Verlierern im deutschen Leitindex. Auch die Anteile von Carl Zeiss Meditec und Sartorius neigen im MDAX zur Kursschwäche.... ► Artikel lesen | |
FRESENIUS | 46,570 | +0,22 % | Verhaltene Kauflaune bei Aktie von Fresenius SE & Co. KGaA (46,88 €) | Die Wertschätzung für die Aktie von Fresenius SE & Co. KGaA hat sich an der Börse am Dienstag kaum geändert. Zuletzt zahlten Investoren für das Wertpapier 46,88 Euro. Wenig getan hat sich heute bislang... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 43,840 | -0,18 % | Fresenius Medical: Erste Hoffnungsschimmer im Chart | Die Fresenius-Medical-Aktie zeigt erste Anzeichen einer möglichen Bodenbildung. Kann der Widerstand bei 44,36 EUR überwunden werden Den vollständigen Artikel lesen ... ► Artikel lesen | |
GERRESHEIMER | 34,920 | -0,51 % | Im Visier der Bafin: Kurssturz bei Gerresheimer | Die Aktie des Spezialverpackungsherstellers Gerresheimer ist am Mittwoch um mehr als 30 Prozent eingebrochen. Die Finanzaufsicht Bafin hat gegen das Unternehmen eine Prüfung des Konzernabschlusses eingeleitet.... ► Artikel lesen | |
GENEDX | 114,05 | 0,00 % | Rackspace US, Inc.: Rackspace Technology und Sema4.ai stellen die erste skalierbare KI-Agent-Lösung für Unternehmen vor | Die unternehmensgerechte Lösung schließt die Lücke zwischen KI-Experimenten und umfassender TransformationSAN ANTONIO, June 18, 2025®) und die Anwendungsmanagement-Expertise von Rackspace mit der fortschrittlichen... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 28,130 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 36,510 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
PLUS THERAPEUTICS | 0,830 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare Insurance Company for CNSide Cerebrospinal Fluid Assay for Metastatic CNS Cancer | HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), announced today that it has signed... ► Artikel lesen | |
ONCOLOGY INSTITUTE | 3,470 | 0,00 % | The Oncology Institute integriert psychologische Betreuung in Krebstherapie | ||
AIRSCULPT TECHNOLOGIES | 7,540 | 0,00 % | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance | MIAMI BEACH, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen |